CONNEQT Health Limited (ASX:CQT)

Australia · Delayed Price · Currency is AUD

0.0210

+0.0010 (5.00%)

Last updated: Sep 11, 2026, 10:03 AM AEST

Market Cap	18.11M +9.7%
Revenue (ttm)	7.96M +31.5%
Net Income	-10.86M
EPS	-0.02
Shares Out	905.43M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,209
Open	0.0210
Previous Close	0.0200
Day's Range	0.0210 - 0.0210
52-Week Range	0.0130 - 0.0640
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2026

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1994

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol CQT

Full Company Profile

Financial Performance

In fiscal year 2026, CONNEQT Health's revenue was 7.96 million, an increase of 31.50% compared to the previous year's 6.05 million. Losses were -10.86 million, -40.32% less than in 2025.

Financial Statements